$PAVM Income Statement | Understand Stock

$PAVM

$2.26 +$0.09 (4.15%) Close

$PAVM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Operating expenses:
Cost of revenue
Gross profit (loss)
Sales and marketing
General and administrative
Amortization of acquired intangible assets
Research and development
Total operating expenses
Operating loss

Other income (expense):
Interest income
Interest expense
Gain on deconsolidation of subsidiary
Change in fair value - equity method investment
Loss on issue and offering costs - Senior Secured Convertible Note
Change in fair value - Senior Secured Convertible Notes
Debt extinguishments loss - Senior Secured Convertible Notes
Debt forgiveness
Change in fair value - derivative liability
Gain on sale of intellectual property
Debt modification expense
Management fee income
Grant income
Other income (expense), net
Income (loss) before provision for income tax
Provision for income taxes
Net income (loss) before noncontrolling interests
Net loss attributable to the noncontrolling interests
Net income (loss) attributable to PAVmed Inc.
Less: Series B Convertible Preferred Stock dividends earned
Less: Deemed dividend on Series Z warrant modification
Less: Preferred Stock dividends earned
Series B Preferred Stock
Series C Preferred Stock
Total less: Preferred Stock dividends earned
Less: Deemed dividend on Subsidiary Preferred Stock attributable to the noncontrolling interests
Less: Deemed dividend
Series C Preferred Stock
Subsidiary Preferred Stock
Net income (loss) attributable to PAVmed Inc. common stockholders
Net loss per share attributable to PAVmed Inc. - basic and diluted

Per share information(1):
Net income (loss) per share attributable to PAVmed Inc. common stockholders – basic (in dollars per share)
Net loss per share attributable to PAVmed Inc. common stockholders – basic and diluted
Weighted average common shares outstanding, basic and diluted
Net income (loss) per share attributable to PAVmed Inc. common stockholders – diluted (in dollars per share)
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)

Comments